Teri Kreisl - Concepedia

Author

Teri Kreisl

National Cancer Institute ORCID

Also Known As

Seema Nagpal, T. Kreisl, T. N. Kreisl, T.N. Kreisl, Teri Kreisl, Teri N Kreisl, Teri N. Kreisl, Teri Nguyen Kreisl

117

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Memorial Sloan Kettering Cancer Center Columbia University National Institute of Neurological Disorders and Stroke

About

Teri Kreisl is an author at National Cancer Institute specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	835
2	Neurology	3	3	307
3	Pathology	3	3	215
4	Health Sciences	1	1	22
5	Neuroscience	1	1	92

Teri Kreisl

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma Teri Kreisl, Lyndon Kim, Kraig Moore, Journal of Clinical Oncology	2008	1.6K
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme John K. Park, Tiffany R. Hodges, Leopold Arko, Journal of Clinical Oncology	2010	358
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial Michael J. Morris, Daniel Castellano, Ken Herrmann, The Lancet UrologyOncologyGenitourinary Cancer177Lu-psma-617 VersusMedicine	2024	189
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM) Teri Kreisl, Andrew B. Lassman, Paul S. Mischel, Journal of Neuro-Oncology Neuro-oncologyGliomaMedicineBrain Tumor BiologyPathology	2008	171
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas Fábio M. Iwamoto, Teri Kreisl, Lyndon Kim, Cancer	2010	118
A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma Teri Kreisl, Wei Zhang, Yazmín Odia, Neuro-Oncology	2011	115
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas Teri Kreisl, Svetlana Kotliarova, John A. Butman, Neuro-Oncology	2010	108
Continuous daily sunitinib for recurrent glioblastoma Teri Kreisl, Perry Smith, Joohee Sul, Journal of Neuro-Oncology Neuro-oncologyGliomaMedicineContinuous Daily SunitinibHigh-grade Gliomas	2012	103
Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy Tyler J. Fraum, Teri Kreisl, Joohee Sul, Journal of Neuro-Oncology ThrombosisNeuro-oncologyIntracranial HemorrhageIschemic StrokeMedicine	2011	92
Ischemic stroke in patients with primary brain tumors Teri Kreisl, Thomas B. Toothaker, Sasan Karimi, Neurology	2008	86

Page 1